ACADIA Pharmaceuticals, Inc. (ACAD)
19.12
-0.59
(-2.99%)
USD |
NASDAQ |
Oct 16, 16:00
19.13
+0.01
(+0.05%)
After-Hours: 20:00
ACADIA Pharmaceuticals Cash from Investing (Quarterly) : -8.529M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.529M |
| March 31, 2026 | 66.28M |
| December 31, 2025 | -55.87M |
| September 30, 2025 | -79.35M |
| June 30, 2025 | -43.29M |
| March 31, 2025 | -124.05M |
| December 31, 2024 | 122.15M |
| September 30, 2024 | -82.46M |
| June 30, 2024 | -56.19M |
| March 31, 2024 | -14.04M |
| December 31, 2023 | -0.347M |
| September 30, 2023 | 34.11M |
| June 30, 2023 | -194.28M |
| March 31, 2023 | 192.52M |
| December 31, 2022 | -17.75M |
| September 30, 2022 | 15.44M |
| June 30, 2022 | -55.80M |
| March 31, 2022 | 131.34M |
| December 31, 2021 | 71.55M |
| September 30, 2021 | -156.32M |
| June 30, 2021 | -17.21M |
| March 31, 2021 | 30.88M |
| December 31, 2020 | -116.96M |
| September 30, 2020 | 152.99M |
| June 30, 2020 | 126.86M |
| Date | Value |
|---|---|
| March 31, 2020 | 29.61M |
| December 31, 2019 | -209.14M |
| September 30, 2019 | 9.923M |
| June 30, 2019 | 10.63M |
| March 31, 2019 | 22.76M |
| December 31, 2018 | -188.95M |
| September 30, 2018 | 31.78M |
| June 30, 2018 | -3.942M |
| March 31, 2018 | 89.62M |
| December 31, 2017 | -18.09M |
| September 30, 2017 | 19.33M |
| June 30, 2017 | 38.30M |
| March 31, 2017 | 52.94M |
| December 31, 2016 | 69.14M |
| September 30, 2016 | -154.91M |
| June 30, 2016 | -7.46M |
| March 31, 2016 | -168.70M |
| December 31, 2015 | 56.35M |
| September 30, 2015 | 8.308M |
| June 30, 2015 | 44.06M |
| March 31, 2015 | 38.47M |
| December 31, 2014 | 40.48M |
| September 30, 2014 | 38.87M |
| June 30, 2014 | -67.51M |
| March 31, 2014 | -99.11M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | 40.21M |
| Biogen, Inc. | -3.839B |
| Insmed, Inc. | 24.51M |
| Arcutis Biotherapeutics, Inc. | -15.22M |
| BioMarin Pharmaceutical, Inc. | -5.102B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 100.78M |
| Cash from Financing (Quarterly) | 10.49M |
| Free Cash Flow | 145.62M |
| Free Cash Flow Per Share (Quarterly) | 0.5536 |
| Free Cash Flow to Equity (Quarterly) | 72.63M |
| Free Cash Flow to Firm (Quarterly) | 95.69M |
| Free Cash Flow Yield | 4.43% |